Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis
Phase 3
Withdrawn
- Conditions
- Relapsing Remitting Multiple Sclerosis
- Interventions
- Drug: placebo
- First Posted Date
- 2007-01-31
- Last Posted Date
- 2014-02-20
- Lead Sponsor
- Anna Tsakiri
- Registration Number
- NCT00429442
- Locations
- 🇩🇰
Department of Neurology, Glostrup University Hospital, Glostrup, Denmark
News
No news found